
Celea Therapeutics
Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).
About
Celea Therapeutics is a clinical-stage biopharmaceutical company focused on developing deupirfenidone, a novel therapeutic candidate for Idiopathic Pulmonary Fibrosis (IPF). The company is a founded entity of PureTech Health plc and aims to establish deupirfenidone as a new standard of care for IPF patients.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- puretechhealth.com
- Headquarters
- Boston, Massachusetts, USA
- Employees
- 83
- Total funding
- $360M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jul 2026 | Funding Round | $180M | |
| 1 Jul 2024 | Financing | $180M |
Tech stack
Detected on puretechhealth.com, last scanned 30 Oct 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Email marketing
- Mailgun
Celea Therapeutics scores 49. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Celea Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Celea Therapeutics is 65 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Celea Therapeutics raised?
Celea Therapeutics has raised a total of $360M in funding. The most recent round on record is Funding Round.
How many employees does Celea Therapeutics have?
Celea Therapeutics has approximately 83 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Celea Therapeutics

